Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Yervoy® (ipilimumab) – Expanded indication
July 24, 2017 – Bristol-Myers Squibb announced the FDA approval of Yervoy (ipilimumab), for the treatment of unresectable or metastatic melanoma in adults and pediatric patients (12 years and older).
